Contegra® 200H12 (UDI 00613994600257)Recalls & reported problems
Medtronic, Inc. · CNDT 200H12 CONTEGRA UNSUPP HDE GBR1-PS · Class f · Implant
All models of Contegra (35)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 11
- Deaths reported
- 0
- Injuries reported
- 11
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 11 adverse event reports that list this exact device (DI 00613994600257), received between Aug 22, 2018 and Aug 29, 2023 — classified as 11 injuries.
The most frequently reported specific device problem is “Insufficient Device Problem Information” (10 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Insufficient Device Problem Information10
- Gradient Increase2
Patient problems
- Insufficient Information4
- No Information4
- Pulmonary Valve Stenosis4
- Pulmonary Insufficiency2
- Tricuspid Regurgitation1
- Tricuspid Valve Stenosis1
Recent adverse event reports
The 11 most recent of 11 reports, in the reporter's own words as published by the FDA.
InjuryAug 29, 2023Gradient Increase; Gradient Increase
MEDTRONIC RECEIVED INFORMATION THAT 6 YEARS AND 4 MONTHS POST IMPLANT OF THIS 12MM PULMONARY VALVED CONDUIT IMPLANTED IN A THEN 11 MONTH OLD PEDIATRIC PATIENT, IT WAS EXPLANTED AND REPLACED WITH A 18MM CONDUIT OF A DIFFERENT MODEL. THE REASON FOR REPLACEMENT WAS REPORTED AS CONDUIT STENOSIS WITH A MAX GRADIENT OF 61-64MMHG AND A MEAN GRADIENT OF 34MMHG. IT WAS ALSO REPORTED THAT A RIGHT VALVE OUTFLOW-TRACT (RVOT) TRANSECTION AND LEFT PULMONARY ARTERY (LPA) PROXIMAL BAND RESECTION WERE PERFORMED CONCOMITANTLY. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Pulmonary Valve Stenosis
MAUDE report 17646612 ↗InjuryMar 14, 2023Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT 1 YEAR AND 9 MONTHS POST IMPLANT OF THIS 12MM PULMONARY VALVED CONDUIT IN A 1 YEAR OLD PEDIATRIC PATIENT, A BALLOON VALVULOPLASTY PROCEDURE WAS PERFORMED. THE REASON FOR REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Insufficient Information
MAUDE report 16538770 ↗InjuryJan 6, 2023Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT IN AN UNKNOWN DURATION POST IMPLANT OF THIS 12MM PULMONARY VALVED CONDUIT IN A 1 YEAR OLD PEDIATRIC PATIENT, IT WAS EXPLANTED AND REPLACED WITH AN UNKNOWN PRODUCT. THE REASON FOR REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Insufficient Information
MAUDE report 16113302 ↗InjuryAug 23, 2021Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT 1 YEAR AND 3 MONTHS POST IMPLANT OF THIS 12MM PULMONARY VALVED CONDUIT IN A (B)(6) OLD PEDIATRIC PATIENT, IT WAS EXPLANTED AND REPLACED WITH A 14MM CONDUIT OF THE SAME MODEL. THE REASON FOR REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Insufficient Information
MAUDE report 12356034 ↗InjuryJan 14, 2021Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT 9 MONTHS POST IMPLANT OF THIS 12MM PULMONARY VALVED CONDUIT IN AN (B)(6)-MONTH-OLD PEDIATRIC PATIENT, IT WAS EXPLANTED AND REPLACED WITH A 16MM CONDUIT OF THE SAME MODEL. THE REASON FOR REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Insufficient Information
MAUDE report 11174377 ↗InjuryJun 29, 2020Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT APPROXIMATELY 4 MONTHS POST IMPLANT OF THIS 12MM PULMONARY VALVED CONDUIT IN AN (B)(6) PEDIATRIC PATIENT, IT WAS EXPLANTED AND REPLACED WITH A HOMOGRAFT. THE REASON FOR REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Information
MAUDE report 10207168 ↗InjuryDec 3, 2019Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT 8 YEARS AND 11 MONTHS POST IMPLANT OF THIS 12MM PULMONARY VALVED CONDUIT IN A (B)(6) PEDIATRIC PATIENT, IT WAS EXPLANTED AND REPLACED WITH A 22MM PULMONARY VALVED CONDUIT OF THE SAME MODEL. THE REASON FOR REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Information; Pulmonary Insufficiency
MAUDE report 9402158 ↗InjuryOct 22, 2019Gradient Increase; Insufficient Device Problem Information; Gradient Increase; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT AN UNKNOWN DURATION POST IMPLANT OF THIS 12MM PULMONARY VALVED CONDUIT IN A PEDIATRIC PATIENT, IT WAS EXPLANTED AND REPLACED WITH AN 18MM PULMONARY VALVED CONDUIT. THE REASON FOR REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Information; Pulmonary Insufficiency; Pulmonary Valve Stenosis
MAUDE report 9220904 ↗InjuryJul 1, 2019Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT 8 YEARS AND 7 MONTHS POST IMPLANT OF THIS 12MM VALVED CONDUIT IN THE TRICUSPID POSITION IN A PEDIATRIC PATIENT, IT WAS EXPLANTED AND REPLACED WITH A 20MM CONDUIT OF THE SAME MODEL. THE REASON FOR REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Information; Tricuspid Regurgitation; Tricuspid Valve Stenosis
MAUDE report 8748110 ↗InjurySep 27, 2018Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT APPROXIMATELY ONE MONTH POST IMPLANT OF THIS 12MM PULMONARY BIOPROSTHETIC VALVED CONDUIT (PLI 20) IMPLANTED IN A (B)(6) PEDIATRIC PATIENT, BILATERAL PULMONARY ARTERY STENOSIS WAS IDENTIFIED. THE PATIENT UNDERWENT BALLOON DILATION/STENTING OF THE RIGHT PULMONARY ARTERY AT THIS TIME. ULTIMATELY, TWO MONTHS AND FOURTEEN DAYS POST IMPLANT, A TRANSCATHETER VALVE WAS IMPLANTED VALVE-IN-VALVE INTO THE VALVED CONDUIT. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Pulmonary Valve Stenosis
MAUDE report 7917025 ↗InjuryAug 22, 2018Insufficient Device Problem Information; Insufficient Device Problem Information
MEDTRONIC RECEIVED INFORMATION THAT 5 YEARS POST IMPLANT OF THIS 12MM PULMONARY VALVED CONDUIT IN A 24 DAY OLD PEDIATRIC PATIENT, THE CONDUIT WAS EXPLANTED AND REPLACED WITH AN 18MM VALVED CONDUIT OF THE SAME MODEL DUE TO SEVERE STENOSIS. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: Pulmonary Valve Stenosis
MAUDE report 7805465 ↗
Other pulmonic valved conduit devices
- Contegra® 200H12Medtronic, Inc. · pulmonic valved conduit1 death29 reports
- Contegra® 200H14Medtronic, Inc. · pulmonic valved conduit2 deaths24 reports
- Contegra® 200H16Medtronic, Inc. · pulmonic valved conduit18 reports
- Contegra® 200H18Medtronic, Inc. · pulmonic valved conduit16 reports
- Contegra® 200SH22Medtronic, Inc. · pulmonic valved conduit12 reports
- Contegra® 200H18Medtronic, Inc. · pulmonic valved conduit12 reports
- Contegra® 200H20Medtronic, Inc. · pulmonic valved conduit11 reports
- Contegra® 200H22Medtronic, Inc. · pulmonic valved conduit10 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page